| Prev Close | 7.91 |
| Day Low/High | 7.75 / 8.36 |
| 52 Wk Low/High | 7.24 / 19.32 |
Coherus BioSciences, Inc. (CHRS)
8.31
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 77.42B |
| Market Cap | 612.42M |
| P/E Ratio | 8.90 |
| Div & Yield | N.A. (N.A) |
Latest News
Trading Notes on 21 Stocks I Currently Own
Here are my takes on stocks in biotech and other companies I own right now.
How Much Longer Can This Action Persist?
One explanation is that there is a 'climbing a wall of worry' dynamic at work.
10 Stocks With Attractive Charts in This Extended Market
As long as these charts hold up, I will continue to hold them regardless of what the indices might do.
The Big Challenge: Putting Idle Capital to Work Without Chasing Too Much
There isn't much choice but to buy strength.
Jobs Numbers Jolt Both Bears and Bulls
The recovery has now occurred so fast that the bulls did not act quickly enough and are again struggling with Fear of Missing Out.
In This Market, Err on the Side of Caution
The selling appears a healthy digestion and we've likely yet to see the indexes reach their highs for the year, but traders should still tread carefully.
Traders Are Still Finding Plenty of Stocks That They Want to Buy
Sentiment is very positive, regardless of what the indices may say.
Biotech Sector Steps Up to Provide Some Strong Action for Traders
The S&P 500 has shown the same pattern for three consecutive days.
A Weak Close Is Going to Have a Significant Impact on Sentiment
It is important for the bulls that the indices close near the highs of the day.
Selling Weak Stocks is Just a Form of Insurance
Defending gains is important as there is little to buy in the market at the moment
Focused on Individual Stocks
Will we see some consolidation and pullbacks as the recent strength is digested?
Here's What Blackstone and KKR Are Buying
Private equity firms' publicly traded equity holdings are a valuable source of ideas for growth and value investors, alike.
2 Big -- and Mispriced -- Biotech Stocks
AbbVie and Gilead Sciences are worth accumulating in a long and deep bear market for biotech.
This Isn't What This Market Needs
A flood of supply in a nervous market isn't a good idea.
Barnes & Noble Adds NFC to Nook: Hot Trends
A look at the day's most searched trends on the Web, including Barnes & Noble after the retailer's announcement it plans to add NFC technology to its Nook e-reader.
Not So Charming
I sold Charming Shoppes ahead of the buyout offer. "One last thing." - Lt. Columbo Paradise Lost. After the close, Ascena Retail Group offers $7.35 a share in cash to acquire Charming Shoppes (CHRS). I had this deal stone cold (I even had the buye...
Charming News
According to a report, the company is for sale. A note on dealReporter says that Charming Shoppes' (CHRS) sale of its Fashion Bug subsidiary has turned into a sale of the entire company. An old name.
54 Levels I Would Buy
It is time for another levels update. Below is an updated list of buy levels on selected stocks that I have recently mentioned on Real Money Pro. (Note: Of the 54 stocks, I would only rate only four -- Ocwen (OCN), iShares FTSE/Xinhua China 25 Index...
Parting Ways
I sold the remainder of a bundle of longs today. Housekeeping items: I eliminated small tag ends in the following stocks this afternoon: Waddell & Reed (WDR), SunTrust (STI), Parker Hannifin (PH), Legg Mason (LM), Fortinet (FTNT), Charming Shoppes (...
50 Levels I Would Buy
It is time for another levels update. Below is an updated list of buy levels on selected stocks that I have recently mentioned on Real Money Pro. (Note: Of the 50 stocks, I would only rate only three -- ProShares UltraShort 20+ Year Treasury (TBT), ...
Levels I Would Buy
Here is an updated list of buy levels for selected stocks that I have mentioned on Real Money Pro. Below is an updated list of buy levels on selected stocks that I have recently mentioned on Real Money Pro. (Note: Of the 39 stocks, I would only rate...
Levels I Would Buy
Here is an updated list of buy levels for selected stocks that I have mentioned on Real Money Pro. Below is an updated list of buy levels on selected stocks that I have recently mentioned on Real Money Pro. (Note: Of the 30 stocks, I would only rate...
Levels I Would Buy
Here is an updated list of buy levels for selected stocks that I have mentioned on Real Money Pro. Below is an updated list of buy levels on selected stocks that I have recently mentioned on Real Money Pro. (Note: Of the 30 stocks, I would only rate...
Levels I Would Buy
Here is an updated list of buy levels for selected stocks that I have mentioned on Real Money Pro. Below is an updated list of buy levels on selected stocks that I have recently mentioned on Real Money Pro. (Note: Of the 30 stocks, I would only rate...
Levels I Would Buy
Here is a list of buy levels for selected stocks that I have recently mentioned on Real Money Pro. As promised yesterday, presented below are my buy levels of selected stocks that I have recently mentioned on Real Money Pro: Charming Shoppes (CHRS),...
Jiggy List
KKR Financial, Pitney Bowes, TBT, Pepsi and Charming Shoppes are all on the move. A list of jiggy stocks (recently mentioned) on the upside: KKR Financial (KFN), Pitney Bowes (PBI), ProShares UltraShort 20+ Year Treasury (TBT), PepsiCo (PEP) and Cha...
Speculative Portfolio Moves
I would be replacing Charming Shoppes, Brocade and Ford with MGIC Investment, KKR Financial and a player to be named later. Housekeeping item: I have sold out more of my Charming Shoppes (CHRS) long. In looking at my speculative basket from back in ...
Speculative Friday (Part Deux)
Back in late November I created a speculative Friday package. I wrote: "As an homage to Jim 'El Capitan' Cramer's 'Mad Money' Speculative Friday segment, I have assembled a basket of four sub-$10-a-share equities that might have appeal for aggressiv...
